VIEW yields 606.06% · MRK yields 2.81%● Live data
📍 VIEW pulled ahead of the other in Year 1
Combined, VIEW + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VIEW + MRK for your $10,000?
View, Inc., a technology company, manufactures and sells smart building products. Its product portfolio includes View Smart Glass that comprise electrochromic glass panels in the form of insulating glass units; and View Net, a cloud-connected network infrastructure offering that can incorporate and power smart building devices. The company's products also include View Immersive Experiences, which transforms View Smart Glass windows into transparent, digital, and interactive surfaces; View Sense modules to measure and optimize light, humidity, temperature, air quality, dust, and noise; View Smart Protect, an intrusion detection solution that can be deployed on View Smart Glass windows to improve the security of a building by detecting glass breakage; View Secure Edge, a plug-and-play edge-to-cloud solution that enables IT and digital innovation teams to securely connect new and existing buildings to the cloud; View Remote Access, a secure access portal that enables IT teams to reduce the cost and cybersecurity risks of maintaining smart buildings; and View Building Performance, a configurable application and web-based tool that enables building managers to measure, optimize, and automate building performance; and View Workplace Experience, a configurable application and web-based tool that enables corporate facilities managers to create productive workplaces. It sells its products to real estate industry, including commercial offices, airports, hospitals and healthcare facilities, multi-family residential, and educational buildings. The company is headquartered in Milpitas, California.
Full VIEW Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.